메뉴 건너뛰기




Volumn 86, Issue 3, 2007, Pages 229-230

Intensive blood transfusion support in acquired hemophilia A [4]

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

EID: 33846687818     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0222-1     Document Type: Letter
Times cited : (5)

References (11)
  • 2
    • 0030776457 scopus 로고    scopus 로고
    • Acquired hemophilia and its treatment
    • Sultan Y (1997) Acquired hemophilia and its treatment. Blood Coagul Fibrinolysis 8(Suppl 1):15S-18S
    • (1997) Blood Coagul Fibrinolysis , vol.8 , Issue.SUPPL. 1
    • Sultan, Y.1
  • 3
    • 0033768130 scopus 로고    scopus 로고
    • The diagnosis and management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)
    • Hay CRM, Baglin TP, Collins PW, Hill FGH, Keeling DM (2000) The diagnosis and management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). Br J Haematol 111:78-90
    • (2000) Br J Haematol , vol.111 , pp. 78-90
    • Hay, C.R.M.1    Baglin, T.P.2    Collins, P.W.3    Hill, F.G.H.4    Keeling, D.M.5
  • 6
    • 0035199305 scopus 로고    scopus 로고
    • Inhibitor treatment: State of the art
    • Shapiro A (2001) Inhibitor treatment: State of the art. Semin Hematol 38:26-34
    • (2001) Semin Hematol , vol.38 , pp. 26-34
    • Shapiro, A.1
  • 7
    • 0037394016 scopus 로고    scopus 로고
    • Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors
    • Delgado J, Yimenez-Yuste V, Hernandez-Navarro F, Villar A (2003) Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 121:21-35
    • (2003) Br J Haematol , vol.121 , pp. 21-35
    • Delgado, J.1    Yimenez-Yuste, V.2    Hernandez-Navarro, F.3    Villar, A.4
  • 8
    • 0020662181 scopus 로고
    • The use of factor eight inhibitor by-passing activity (FEIBA Immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors
    • FEIBA Study Group
    • Hilgartner MW, Knatterud GL, FEIBA Study Group (1983) The use of factor eight inhibitor by-passing activity (FEIBA Immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors. Blood 61:36-40
    • (1983) Blood , vol.61 , pp. 36-40
    • Hilgartner, M.W.1    Knatterud, G.L.2
  • 9
    • 0032837867 scopus 로고    scopus 로고
    • The use of agents that by-pass factor VIII inhibitors in patients with hemophilia
    • Roberts HR (1999) The use of agents that by-pass factor VIII inhibitors in patients with hemophilia. Vox Sang 77(Suppl 1):38-41
    • (1999) Vox Sang , vol.77 , Issue.SUPPL. 1 , pp. 38-41
    • Roberts, H.R.1
  • 10
    • 0030700329 scopus 로고    scopus 로고
    • The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicenter study
    • Hay CRM, Negrier C, Ludlam CA (1997) The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicenter study. Thromb Haemost 78:1463-1467
    • (1997) Thromb Haemost , vol.78 , pp. 1463-1467
    • Hay, C.R.M.1    Negrier, C.2    Ludlam, C.A.3
  • 11
    • 33846669469 scopus 로고    scopus 로고
    • Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia
    • Franchini M, Girelli D, Olivieri O et al (2006) Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A. Haemophilia 12:448-451
    • (2006) A Haemophilia , vol.12 , pp. 448-451
    • Franchini, M.1    Girelli, D.2    Olivieri, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.